Cellebrite DI revenue chief sells 22,390 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cellebrite DI Ltd. (CLBT) Global Chief Revenue Officer Marcus Jewell sold 12,462 ordinary shares on November 16, 2026, at a weighted average price of $11.5522 per share across transactions ranging from $11.41 to $11.65. The shares had been granted as restricted stock units on November 15, 2023, and their disposition was associated with tax obligations from vesting. On November 17, he sold 9,928 ordinary shares at a weighted average price of $10.6608 per share, in transactions ranging from $10.45 to $11.04, under a Rule 10b5-1 plan adopted August 14, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary shares, par value NIS 0.00001 F3, F4 | 9,928 | $10.6608 | $106K |
| Sale | Ordinary shares, par value NIS 0.00001 F1, F2 | 12,462 | $11.5522 | $144K |
Footnotes (4)
- F1. The shares reported as disposed herein were granted on November 15, 2023, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.41 to $11.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
- F3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2026.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.45 to $11.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
restricted stock units financial
Rule 10b5-1 trading plan regulatory
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Was Marcus Jewell's November 17 CLBT sale made under a trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.